From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Monoclonal antibody
TypeWhole antibody
Clinical data
ATC code
  • none
CAS Number
  • none
 ☒N☑Y (what is this?)  (verify)

Elsilimomab (also known as B-E8) is a mouse monoclonal antibody[1] and an immunosuppressive drug.[citation needed]

It (OPR-003) targets (and blocks) Interleukin-6.[2]

It has undergone a number of early stage clinical trails, e.g. for lymphoma and myeloma.[3]

It was used as a template to develop a high-affinity, antagonist, fully human anti-IL-6 mAb 1339.[3]


  1. ^ "WHO Drug Information" (PDF). p11:immunoglobulin G1, anti-(human interleukin 6) (mouse monoclonal B-E8 heavy chain), disulfide with mouse monoclonal B-E8 k-chain, dimer
  2. ^ "First Fully Human Anti-IL6 Antibody Under Development". Oct 2006.
  3. ^ a b Fulciniti, M; Hideshima, T; Vermot-Desroches, C; Pozzi, S; Nanjappa, P; Shen, Z; Patel, N; Smith, ES; et al. (2009). "A high-affinity fully human anti-IL-6 mAb (OP-R003-1, 1339) for the treatment of Multiple Myeloma". Clinical Cancer Research. 15 (23): 7144–52. doi:10.1158/1078-0432.CCR-09-1483. PMC 2787636. PMID 19934301.